Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeShare-based CompensationShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Healthy Extracts (HYEX) Depreciation & Amortization (CF) (2016 - 2025)

Healthy Extracts (HYEX) has 11 years of Depreciation & Amortization (CF) data on record, last reported at $634.0 in Q3 2025.

  • For Q3 2025, Depreciation & Amortization (CF) rose 210.78% year-over-year to $634.0; the TTM value through Sep 2025 reached $1533.0, up 644.17%, while the annual FY2024 figure was -$139.0, 106.33% down from the prior year.
  • Depreciation & Amortization (CF) reached $634.0 in Q3 2025 per HYEX's latest filing, up from $491.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $1275.0 in Q1 2021 and bottomed at -$1096.0 in Q2 2024.
  • Average Depreciation & Amortization (CF) over 5 years is $492.79, with a median of $549.0 recorded in 2022.
  • Peak YoY movement for Depreciation & Amortization (CF): plummeted 299.64% in 2024, then surged 210.78% in 2025.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $1275.0 in 2021, then crashed by 56.94% to $549.0 in 2022, then changed by 0.0% to $549.0 in 2023, then tumbled by 62.84% to $204.0 in 2024, then soared by 210.78% to $634.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Depreciation & Amortization (CF) were $634.0 in Q3 2025, $491.0 in Q2 2025, and $204.0 in Q1 2025.